Literature DB >> 18433068

Sirolimus conversion for renal preservation in liver transplantation: not so fast.

Geoffrey S Jensen, Alexander Wiseman, James F Trotter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433068     DOI: 10.1002/lt.21452

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  3 in total

1.  Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function.

Authors:  Kentaro Ide; Yuka Tanaka; Takashi Onoe; Masataka Banshodani; Hirofumi Tazawa; Yuka Igarashi; Nabin Bahadur Basnet; Marlen Doskali; Hirotaka Tashiro; Hideki Ohdan
Journal:  J Transplant       Date:  2011-07-06

2.  Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model.

Authors:  José Sereno; Ana M Romão; Belmiro Parada; Patrícia Lopes; Eugénia Carvalho; Frederico Teixeira; Flávio Reis
Journal:  J Pharmacol Pharmacother       Date:  2012-04

3.  A Decade of Experience Using mTor Inhibitors in Liver Transplantation.

Authors:  Jeffrey Campsen; Michael A Zimmerman; Susan Mandell; Maria Kaplan; Igal Kam
Journal:  J Transplant       Date:  2011-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.